Eating every 2-3 hours becomes especially important to prevent blood sugar fluctuations
Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Kawakubo M, Buchanan TA
Glp-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
This is usually only recommended for individuals on high maintenance doses who wish to minimize the volume of the injection
GLP-1 Therapies: Context & Challenge Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are FDA-approved for the treatment of type 2 diabetes and obesity
What Research Shows About Every-Other-Week GLP-1 Dosing Currently, no major clinical trials have specifically tested every-other-week dosing for standard semaglutide or tirzepatide formulations